Recombinant viruses obtained from co-infection in vitro with a live vaccinia-vectored influenza vaccine and a naturally occurring cowpox virus display different plaque phenotypes and loss of the transgene

Vaccine

Volumn 23, Issue 4, 2004, Pages 499-506

  Hansen, Hilde ^a   Okeke, Malachy Ifeanyi ^a   Nilssen, Øivind ^b   Traavik, Terje ^a,c  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c University of Tromsö   (Norway)

Author keywords

MVA recombinant vaccines; Orthopoxvirus; Poxvirus; Risk assessment; Safety

Indexed keywords

INFLUENZA VACCINE; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; COWPOX VIRUS; DNA MODIFICATION; GENE DELETION; GENE FREQUENCY; GENETIC RECOMBINATION; GENETIC STABILITY; HOST CELL; HYBRID; IN VITRO STUDY; INFLUENZA VIRUS; MONITORING; NONHUMAN; NORWAY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; TRANSGENE; VACCINIA VIRUS; VIRUS GENE; VIRUS INFECTION; VIRUS ISOLATION; VIRUS PLAQUE; VIRUS RECOMBINANT; VIRUS STRAIN;

ANIMALS; BLOTTING, SOUTHERN; CELL LINE; CERCOPITHECUS AETHIOPS; COWPOX VIRUS; DNA, VIRAL; INFLUENZA VACCINES; ORGANISMS, GENETICALLY MODIFIED; PHENOTYPE; PLAQUE ASSAY; POLYMERASE CHAIN REACTION; REASSORTANT VIRUSES; RECOMBINATION, GENETIC; VACCINIA VIRUS; VERO CELLS; VIRAL VACCINES;

EID: 7744242708     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.06.032     Document Type: Article

References (44)

1. M.E. Perkus, J. Tartaglia, and E. Paoletti Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases J. Leukoc. Biol. 58 1 1995 1 13
2. F. Fenner, D.A. Henderson, I. Arita, Z. Jezek, and I.D. Ladnyj Smallpox and its Eradication 1988 World Health Organization Geneva
3. C.A. Hanlon, M. Niezgoda, A.N. Hamir, C. Schumacher, H. Koprowski, and C.E. Rupprecht First North American field release of a vaccinia - rabies glycoprotein recombinant virus J. Wildl. Dis. 34 2 1998 228 239
4. P.P. Pastoret, and B. Brochier Epidemiology and control of fox rabies in Europe Vaccine 17 13-14 1999 1750 1754
5. C.E. Rupprecht, L. Blass, K. Smith, L.A. Orciari, M. Niezgoda, and S.G. Whitfield Human infection due to recombinant vaccinia - rabies glycoprotein virus N. Engl. J. Med. 345 8 2001 582 586
6. R.R. Redfield, D.C. Wright, W.D. James, T.S. Jones, C. Brown, and D.S. Burke Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease N. Engl. J. Med. 316 11 1987 673 676
7. W. Altenburger, C.P. Suter, and J. Altenburger Partial deletion of the human host range gene in the attenuated vaccinia virus MVA Arch Virol. 105 1-2 1989 15 27
8. H. Meyer, G. Sutter, and A. Mayr Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence J. Gen. Virol. 72 5 1991 1031 1038
9. M.W. Carroll, and B. Moss Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a non-human mammalian cell line Virology 238 2 1997 198 211
10. T.J. Blanchard, A. Alcami, P. Andrea, and G.L. Smith Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine J. Gen. Virol. 79 Pt 5 1998 1159 1167
11. K.J. Stittelaar, T. Kuiken, R.L. de Swart, G. van Amerongen, H.W. Vos, and H.G. Niesters Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques Vaccine 19 27 2001 3700 3709
12. T. Traavik Environmental risk of genetically engineered vaccines D.K. Letourneau B.E. Burrows Genetically engineered organisms: assessing environmental and human health effects 2002 CRC Press USA 331 353
13. A.C. Crouch, D. Baxby, C.M. McCracken, R.M. Gaskell, and M. Bennett Serological evidence for the reservoir hosts of cowpox virus in British wildlife Epidemiol. Infect. 115 1 1995 185 191
14. D. Boulanger, A. Crouch, B. Brochier, M. Bennett, J. Clement, and R.M. Gaskell Serological survey for orthopoxvirus infection of wild mammals in areas where a recombinant rabies virus is used to vaccinate foxes Vet. Rec. 138 11 1996 247 249
15. T. Sandvik, M. Tryland, H. Hansen, R. Mehl, U. Moens, and O. Olsvik Naturally occurring orthopoxviruses: potential for recombination with vaccine vectors J. Clin. Microbiol. 36 9 1998 2542 2547
16. M. Tryland, T. Sandvik, R. Mehl, M. Bennett, T. Traavik, and O. Olsvik Serosurvey for orthopoxviruses in rodents and shrews from Norway J. Wildl. Dis. 34 2 1998 240 250
17. J. Chantrey, H. Meyer, D. Baxby, M. Begon, K.J. Bown, and S.M. Hazel Cowpox: reservoir hosts and geographic range Epidemiol. Infect. 122 3 1999 455 460
18. J.J. Esposito, and J.C. Knight Orthopoxvirus DNA: a comparison of restriction profiles and maps Virology 143 1 1985 230 251
19. B. Moss Poxviridae: the viruses and their replication B. Roizman P. Howley S. Straus M. Martin G. DE R. Lamb Fields Virology 2001 Lippincott Williams & Wilkins Philadelphia 2849 2883
20. R.J. Jackson, A.J. Ramsay, C.D. Christensen, S. Beaton, D.F. Hall, and I.A. Ramshaw Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox J. Virol. 75 3 2001 1205 1210
21. V.I. Chernos, T.P. Antonova, and T.G. Senkevich Recombinants between vaccinia and ectromelia viruses bearing the specific pathogenicity markers of both parents J. Gen. Virol. 66 Pt3 1985 621 626
22. L.A. Ball High-frequency homologous recombination in vaccinia virus DNA J. Virol. 61 6 1987 1788 1795
23. Z. Fathi, L.M. Dyster, J. Seto, R.C. Condit, and E.G. Niles Intragenic and intergenic recombination between temperature-sensitive mutants of vaccinia virus J. Gen. Virol. 72 Pt11 1991 2733 2737
24. W. Block, C. Upton, and G. McFadden Tumorigenic poxviruses: genomic organization of malignant rabbit virus, a recombinant between Shope fibroma virus and myxoma virus Virology 140 1 1985 113 124
25. P.D. Gershon, R.P. Kitching, J.M. Hammond, and D.N. Black Poxvirus genetic recombination during natural virus transmission J. Gen. Virol. 70 Pt 2 1989 485 489
26. G. Sutter, L.S. Wyatt, P.L. Foley, J.R. Bennink, and B. Moss A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus Vaccine 12 11 1994 1032 1040
27. M. Tryland, T. Sandvik, H. Hansen, G. Haukenes, L. Holtet, and M. Bennett Characteristics of four cowpox virus isolates from Norway and Sweden APMIS 106 6 1998 623 635
28. F.M. Ausubel, R. Brent, R.E. Kingstone, D.D. Moore, J.G. Seidman, and J.A. Smith Current Protocols in Molecular Biology 2000 John Wiley & Sons, Inc.
29. G. Antoine, F. Scheiflinger, F. Dorner, and F.G. Falkner The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses Virology 244 2 1998 365 396
30. S.N. Shchelkunov, P.F. Safronov, A.V. Totmenin, N.A. Petrov, O.I. Ryazankina, and V.V. Gutorov The genomic sequence analysis of the left and right species-specific terminal region of a cowpox virus strain reveals unique sequences and a cluster of intact ORFs for immunomodulatory and host range proteins Virology 243 2 1998 432 460
31. J. Esposito, R. Condit, and J. Obijeski The preparation of orthopoxvirus DNA J. Virol. Methods 2 3 1981 175 179
32. J. Sambrook, E.F. Fritsch, T. Maniatis, and Molecular Cloning: a Laboratory Manual 1989 Cold Spring Harbour Laboratory NY
33. D.J. Pickup, B.S. Ink, B.L. Parsons, W. Hu, and W.K. Joklik Spontaneous deletions and duplications of sequences in the genome of cowpox virus Proc. Natl. Acad. Sci. U.S.A. 81 21 1984 6817 6821
34. G.L. Smith, and A. Vanderplasschen Extracellular enveloped vaccinia virus. Entry, egress, and evasion Adv. Exp. Med. Biol. 440 1998 395 414
35. D.J. Pulford, H. Meyer, and D. Ulaeto Orthologs of the vaccinia A13L and A36R virion membrane protein genes display diversity in species of the genus Orthopoxvirus Arch. Virol. 147 5 2002 995 1015
36. D. Spehner, R. Drillien, F. Proamer, C. Houssais-Pecheur, M.A. Zanta, and M. Geist Enveloped virus is the major virus form produced during productive infection with the modified vaccinia virus Ankara strain Virology 273 1 2000 9 15
37. J.P. Thompson, P.C. Turner, A.N. Ali, B.C. Crenshaw, and R.W. Moyer The effects of serpin gene mutations on the distinctive pathobiology of cowpox and rabbitpox virus following intranasal inoculation of Balb/c mice Virology 197 1 1993 328 338
38. J.C. Ramirez, M.M. Gherardi, and M. Esteban Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western reserve strain and advantages as a vaccine J. Virol. 74 2 2000 923 933
39. G. Sutter, and B. Moss Non-replicating vaccinia vector efficiently expresses recombinant genes Proc. Natl. Acad. Sci. U.S.A. 89 22 1992 10847 10851
40. D.O. Willer, M.J. Mann, W. Zhang, and D.H. Evans Vaccinia virus DNA polymerase promotes DNA pairing and strand-transfer reactions Virology 257 2 1999 511 523
41. F.Q. Hu, C.A. Smith, and D.J. Pickup Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor Virology 204 1 1994 343 356
42. V.N. Loparev, J.M. Parsons, J.C. Knight, J.F. Panus, C.A. Ray, and R.M. Buller A third distinct tumor necrosis factor receptor of orthopoxviruses Proc. Natl. Acad. Sci. U.S.A. 95 7 1998 3786 3791
43. Y. Ichihashi, S. Matsumoto, and S. Dales Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination Virology 46 3 1971 507 532
44. D. Spehner, S. Gillard, R. Drillien, and A. Kirn A cowpox virus gene required for multiplication in Chinese hamster ovary cells J. Virol. 62 4 1988 1297 1304